Eagle Strategies’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
Eagle Strategies's PFE Position: Q2 2026 in Review
Eagle Strategies increased its Pfizer (PFE) stake by 1.5% in Q2 2026, buying an estimated $5.28K and bringing the position to 13,556 shares worth $326K. The position accounts for 0.03% of the portfolio, ranked #226.
Eagle Strategies first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $540K in Q4 2021. 1,421 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Eagle Strategies held 13,556 shares of Pfizer worth $326K as of Q2 2026.
- Eagle Strategies bought 202 Pfizer shares in Q2 2026, an estimated $5.28K.
- Pfizer made up 0.03% of Eagle Strategies's portfolio in Q2 2026, its #226 holding.
- Eagle Strategies first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Eagle Strategies's Pfizer position peaked at $540K in Q4 2021.
- 1,421 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Eagle Strategies's 13F filing for Q2 2026, filed 21 Jul 2026.